|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Parikesit D, Mochtar CA, Umbas R and Hamid
AR: The impact of obesity towards prostate diseases. Prostate Int.
4:1–6. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hu MB, Liu SH, Jiang HW, Bai PD and Ding
Q: Obesity affects the biopsy-mediated detection of prostate
cancer, particularly high-grade prostate cancer: A dose-response
meta-analysis of 29,464 patients. PLoS One. 9:e1066772014.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hu MB, Xu H, Bai PD, Jiang HW and Ding Q:
Obesity has multifaceted impact on biochemical recurrence of
prostate cancer: A dose-response meta-analysis of 36,927 patients.
Med Oncol. 31:8292014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Calle EE, Rodriguez C, Walker-Thurmond K
and Thun MJ: Overweight, obesity, and mortality from cancer in a
prospectively studied cohort of U.S. adults. N Engl J Med.
348:1625–1638. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Shibue T, Brooks MW and Weinberg RA: An
integrin-linked machinery of cytoskeletal regulation that enables
experimental tumor initiation and metastatic colonization. Cancer
Cell. 24:481–498. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Liu Z, Xiao Y, Yuan Y, Zhang X, Qin C, Xie
J, Hao Y, Xu T and Wang X: Effects of oleic acid on cell
proliferation through an integrin-linked kinase signaling pathway
in 786-O renal cell carcinoma cells. Oncol Lett. 5:1395–1399. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kang L, Mokshagundam S, Reuter B, Lark DS,
Sneddon CC, Hennayake C, Williams AS, Bracy DP, James FD, Pozzi A,
et al: Integrin-linked kinase in muscle is necessary for the
development of insulin resistance in diet-induced obese mice.
Diabetes. 65:1590–1600. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Tabur S, Oztuzcu S, Oguz E, Demiryürek S,
Dagli H, Alasehirli B, Ozkaya M and Demiryürek AT: Evidence for
elevated (LIMK2 and CFL1) and suppressed (ICAM1, EZR, MAP2K2 and
NOS3) gene expressions in metabolic syndrome. Endocrine.
53:465–470. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Nguewa PA and Calvo A: Use of transgenic
mice as models for prostate cancer chemoprevention. Curr Mol Med.
10:705–718. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Xu H, Hu MB, Bai PD, Zhu WH, Liu SH, Hou
JY, Xiong ZQ, Ding Q and Jiang HW: Proinflammatory cytokines in
prostate cancer development and progression promoted by high-fat
diet. Biomed Res Int. 2015:249741–7. 2015.PubMed/NCBI
|
|
12
|
Bravou V, Antonacopoulou A, Papanikolaou
S, Nikou S, Lilis I, Giannopoulou E and Kalofonos HP: Focal
adhesion proteins α- and β-Parvin are overexpressed in human
colorectal cancer and correlate with tumor progression. Cancer
Invest. 33:387–397. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Gao J, Aksoy BA, Dogrusoz U, Dresdner G,
Gross B, Sumer SO, Sun Y, Jacobsen A, Sinha R, Larsson E, et al:
Integrative analysis of complex cancer genomics and clinical
profiles using the cBioPortal. Sci Signal. 6:pl12013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Cerami E, Gao J, Dogrusoz U, Gross BE,
Sumer SO, Aksoy BA, Jacobsen A, Byrne CJ, Heuer ML, Larsson E, et
al: The cBio cancer genomics portal: An open platform for exploring
multidimensional cancer genomics data. Cancer Discov. 2:401–404.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Center MM, Jemal A, Lortet-Tieulent J,
Ward E, Ferlay J, Brawley O and Bray F: International variation in
prostate cancer incidence and mortality rates. Eur Urol.
61:1079–1092. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Allott EH, Masko EM and Freedland SJ:
Obesity and prostate cancer: Weighing the evidence. Eur Urol.
63:800–809. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Toren P, Mora BC and Venkateswaran V:
Diet, obesity and cancer progression: Are adipocytes the link? LPI.
6:37–45. 2013. View Article : Google Scholar
|
|
18
|
Mavropoulos JC, Buschemeyer WC III, Tewari
AK, Rokhfeld D, Pollak M, Zhao Y, Febbo PG, Cohen P, Hwang D, Devi
G, et al: The effects of varying dietary carbohydrate and fat
content on survival in a murine LNCaP prostate cancer xenograft
model. Cancer Prev Res (Phila). 2:557–565. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Cho HJ, Kwon GT, Park H, Song H, Lee KW,
Kim JI and Park JHY: A high-fat diet containing lard accelerates
prostate cancer progression and reduces survival rate in mice:
Possible contribution of adipose tissue-derived cytokines.
Nutrients. 7:2539–2561. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kobayashi N, Barnard RJ, Said J,
Hong-Gonzalez J, Corman DM, Ku M, Doan NB, Gui D, Elashoff D, Cohen
P and Aronson WJ: Effect of low-fat diet on development of prostate
cancer and Akt phosphorylation in the Hi-Myc transgenic mouse
model. Cancer Res. 68:3066–3073. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Bianchi-Frias D, Hernandez SA, Coleman R,
Wu H and Nelson PS: The landscape of somatic chromosomal copy
number aberrations in GEM models of prostate carcinoma. Mol Cancer
Res. 13:339–347. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Gelman IH: How the TRAMP model
revolutionized the study of prostate cancer progression. Cancer
Res. 76:6137–6139. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Graff JR, Deddens JA, Konicek BW, Colligan
BM, Hurst BM, Carter HW and Carter JH: Integrin-linked kinase
expression increases with prostate tumor grade. Clin Cancer Res.
7:1987–1991. 2001.PubMed/NCBI
|
|
24
|
Cortez V, Nair BC, Chakravarty D and
Vadlamudi RK: Integrin-linked kinase 1: Role in hormonal cancer
progression. Front Biosci (Schol Ed). 3:788–796. 2011.PubMed/NCBI
|
|
25
|
Sepulveda JL and Wu C: The parvins. Cell
Mol Life Sci. 63:25–35. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Mongroo PS, Johnstone CN, Naruszewicz I,
Leung-Hagesteijn C, Sung RK, Carnio L, Rustgi AK and Hannigan GE:
Beta-parvin inhibits integrin-linked kinase signaling and is
downregulated in breast cancer. Oncogene. 23:8959–8970. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wu CF, Ng KF, Chen CS, Chang PL, Chuang
CK, Weng WH, Liao SK and Pang ST: Expression of parvin-beta is a
prognostic factor for patients with urothelial cell carcinoma of
the upper urinary tract. Br J Cancer. 103:852–860. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Eslami A, Miyaguchi K, Mogushi K, Watanabe
H, Okada N, Shibuya H, Mizushima H, Miura M and Tanaka H: PARVB
overexpression increases cell migration capability and defines high
risk for endophytic growth and metastasis in tongue squamous cell
carcinoma. Br J Cancer. 112:338–344. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Mizuno K: Signaling mechanisms and
functional roles of cofilin phosphorylation and dephosphorylation.
Cell Signal. 25:457–469. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Lu LI, Fu NI, Luo XU, Li XY and Li XP:
Overexpression of cofilin 1 in prostate cancer and the
corresponding clinical implications. Oncol Lett. 9:2757–2761. 2015.
View Article : Google Scholar : PubMed/NCBI
|
